US medical device company Adagio Medical raises $42.5m in Series E
Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]
Biotronik has bagged US FDA approval for its high-voltage cardiac rhythm management (CRM) devices – Acticor and Rivacor range of devices for treating heart arrhythmia or cardiac arrhythmias. The six new tachycardia solutions approved by the FDA are Rivacor VR-T, Rivacor DR-T, Rivacor HF-T QP, Acticor DX, Acticor CRT-DX and Acticor CRT-DX Bipolar. Biotronik is […]
Continue reading …
US finished-dose generic drug company Vitruvias Therapeutics and Chinese pharma company Sinotherapeutics have announced the US launch of a bioequivalent FDA-approved version of antiarrhythmic drug Rythmol SR, known generically as propafenone hydrochloride. Rythmol SR, which is an oral administered drug, is supplied in extended-release capsules of 225, 325 and 425 mg. The antiarrhythmic drug is […]
Continue reading …
Business News Today
- PostBank Uganda launches new debit card – UnionPay PostCard
- Lightnet Group strikes partnership with Thailand’s Siam Commercial Bank
- JinkoSolar to divest stake in 1.2GW Sweihan Power Station in Abu Dhabi
- CBAK Energy to supply battery packs to EV manufacturer Kandi Vehicles
- Flanagan Associates acquired by World Insurance Associates
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
